AMPHETAMINE SULFATE | A083901 | LANNETT CO INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Acknowledgement Letter From FDA DDM to Lachman Consultant Services Inc FDA-2014-P-1038 · 6 docket documents Lachman Consultant Services Inc. filed a petition requesting that the FDA determine Amphetamine Sulfate Tablets USP in strengths of 2.5 mg, 15 mg, 20 mg, and 30 mg are suitable for submission as an ANDA. The FDA acknowledged receipt of the petition and assigned it docket number FDA-2014-P-1038 on Se | Other | 2014-09-02 | Withdrawn | — |
Lachman Consultant Services, Inc. - Citizen Petition FDA-2009-P-0273 · 5 docket documents Lachman Consultant Services, Inc. filed this petition on behalf of a client requesting that the FDA determine whether Amphetamine Sulfate 5 mg and 10 mg Tablets (NDA 83-901 Products 001 and 002) held by Lannett Company, Inc. was voluntarily withdrawn or withheld from sale for reasons of safety or ef | 505(q) | 2009-06-18 | Open | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.